Real-World Analysis of Adverse Events in Patients With Triple-Negative Breast Cancer Receiving Therapy per KEYNOTE-522
Mara Hofherr, Andrew A. Davis, Spenser January, Farah Raheem et autres
0 citationsJCO Oncology Practice
Farah Raheem
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
23Publications signalées
222Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Advanced Breast Cancer TherapiesBreast Cancer Treatment StudiesHER2/EGFR in Cancer ResearchCancer Treatment and PharmacologyLung Cancer Treatments and Mutations
Publications récentes
Clinical Pharmacists and Industry: Guidelines for Professional Interactions
Adriane N. Irwin, Sarah A. Spinler, Jordan Baye, Marilyn N. Bulloch et autres
0 citationsJACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY
Abstract PS4-10-06: Analysis of Adverse Events and Outcomes of Adjuvant Therapies in TNBC as Monotherapy and Combination: Pembrolizumab, Capecitabine, and Olaparib
Rodolfo Garza-Morales, Farah Raheem, Drake Alton, S. Sharma et autres
0 citationsClinical Cancer Research
Abstract P2-12-05: Retrospective Study of Drug-Induced Interstitial Lung Disease in Breast Cancer Patients Treated at Mayo Clinic between the Years of 2018-2023 (Real World Experience)
Farah Raheem, Alejandro Diaz-Arumir, Claire Yee, Lida A. Mina
0 citationsClinical Cancer Research
Abstract P4-05-01: Retrospective Analysis of fam-Trastuzumab Deruxtecan Treatment in Advanced Breast Cancer Patients: Real World Experience at Mayo Clinic in Arizona (2022-2024)
Drake Alton, Farah Raheem, Felipe Batalini, Claire Yee et autres
0 citationsClinical Cancer Research
Abstract P1-11-08: Practice patterns and uptake of adjuvant abemaciclib in high risk localized hormone receptor positive, HER2-negative breast cancer
Sarah Premji, Tanmayi Pai, S. Liddell, Nathaniel E. Wiest et autres
1 citationClinical Cancer Research
Pulmonary toxicities in patients (pts) with metastatic breast cancer (mBC) treated with trastuzumab deruxtecan (T-DXd): The Mayo Clinic Enterprise Experience, updated.
Jenna Hoppenworth, Claire Yee, Matt Truman, Jodi L. Taraba et autres
0 citationsJournal of Clinical Oncology
Time to complete oncology pharmacist tasks: A joint opinion of the Hematology/Oncology Pharmacy Association and American College of Clinical Pharmacy's Hematology/Oncology Practice and Research Network
Shawn P. Griffin, Jessie Signorelli, Farah Raheem, Kristin Adler et autres
2 citationsJournal of Oncology Pharmacy Practice
Retrospective Analysis of Osteonecrosis of the Jaw in Breast Cancer Patients Receiving Bone Modifying Agents for Bone Metastases
Taylor Praska, Cassia R. Griswold, Melissa Noyes, Lida A. Mina et autres
0 citationsSSRN Electronic Journal
QTc prolongation across CDK4/6 inhibitors: a systematic review and meta-analysis of randomized controlled trials
Pedro Cotta Abrahão Reis, Alice Deberaldini Marinho, Ana Carolina Marin Comini, Débora Pinheiro Xavier et autres
12 citationsJNCI Cancer Spectrum
Abstract PS14-06: Real-World Analysis of Adverse Events in Patients with Triple Negative Breast Cancer Receiving Therapy per KEYNOTE-522
Mara Hofherr, Katherine Clifton, Spenser E. January, Emily Owen et autres
3 citationsCancer Research
Abstract PS14-02: Real-world analysis comparing Black and White patients with triple-negative breast cancer receiving therapy per KEYNOTE-522
Mara Hofherr, Andrew A. Davis, Spenser E. January, Emily Owen et autres
3 citationsCancer Research
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.